Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol.

Lei Deng Gulidanna ShayanWei JiangNan BiLuhua Wang

Published in: Thoracic cancer (2024)

The present study is the first randomized phase III trial designed to evaluate the efficacy of higher versus lower dose cTRT in ES-SCLC, providing evidence for future clinical practice in prolonging survival of patients with ES-SCLC.

Keyphrases

phase iii
double blind
open label
clinical trial
placebo controlled
study protocol
small cell lung cancer
phase ii
clinical practice
randomized controlled trial
cross sectional
radiation therapy
radiation induced